APA (7th ed.) Citation

S, W., KW, C., D, W., X, M., S, L., G, H., . . . S, L. (2024). Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. Nature communications, 15(1), 4301. https://doi.org/10.1038/s41467-024-48514-8

Chicago Style (17th ed.) Citation

S, Wang, et al. "Human CD4-binding Site Antibody Elicited by Polyvalent DNA Prime-protein Boost Vaccine Neutralizes Cross-clade Tier-2-HIV Strains." Nature Communications 15, no. 1 (2024): 4301. https://doi.org/10.1038/s41467-024-48514-8.

MLA (9th ed.) Citation

S, Wang, et al. "Human CD4-binding Site Antibody Elicited by Polyvalent DNA Prime-protein Boost Vaccine Neutralizes Cross-clade Tier-2-HIV Strains." Nature Communications, vol. 15, no. 1, 2024, p. 4301, https://doi.org/10.1038/s41467-024-48514-8.